Klivira
Request demo

Optimizing Allergy & Immunology CoverMyMeds Integration

Klivira provides a robust solution for allergy & immunology CoverMyMeds integration, automating the electronic prior authorization process for high-cost medications and therapies specific to this specialty.

Revenue cycle directors and prior authorization coordinators in allergy & immunology practices face unique challenges in securing timely approvals for vital treatments. The complexity of biologics, IVIG, and immunotherapy PAs, coupled with varying payer requirements, often leads to administrative bottlenecks and delays in patient care. Klivira addresses these challenges by streamlining the ePA workflow.

The Allergy & Immunology PA Landscape

Allergy and immunology practices frequently manage patients requiring complex, high-cost therapies such as biologics for severe asthma or atopic dermatitis, IVIG/SCIG for primary immunodeficiencies, and allergen immunotherapy. Securing prior authorization for these treatments is critical but often manual and resource-intensive, requiring detailed clinical documentation and adherence to specific payer criteria.

Key Prior Authorization Triggers in Allergy & Immunology

  • Asthma Biologics (e.g., Xolair, Dupixent, Nucala, Cinqair, Fasenra, Tezspire)
  • Immunoglobulin Therapy (IVIG/SCIG)
  • Allergen Immunotherapy Extracts (e.g., sublingual or injectable)
  • Specialty Injectables for Urticaria or Angioedema
  • Advanced Diagnostic Imaging for Respiratory Conditions
  • Specific Immunomodulators

Seamless CoverMyMeds Integration for A&I Medications

Klivira's platform integrates directly with CoverMyMeds, leveraging their extensive payer connectivity for electronic prior authorization (ePA) of specialty drugs common in allergy & immunology. This integration streamlines the submission process, enabling practices to initiate, track, and manage medication PAs efficiently, reducing the need for manual portal entries or fax submissions.

EMR-Driven Workflow for A&I Prior Authorizations

Our integration with leading EMR systems via SMART on FHIR allows for automated extraction of necessary clinical data—including diagnosis codes (ICD-10), lab results (e.g., IgE, eosinophil counts), and medication orders—directly from the patient chart. This data populates the CoverMyMeds submission, ensuring accuracy and completeness without manual data entry, a critical factor for biologics and IVIG.

Navigating Payer-Specific Requirements and Clinical Guidelines

While CoverMyMeds handles many ePA submissions, Klivira augments this by managing payer-specific nuances and documentation requirements often encountered in A&I. Our system ensures that submissions align with clinical guidelines from bodies like the AAAAI and ACAAI, providing the necessary evidence for approval and reducing denials for high-cost therapies.

Operational Impact for Allergy & Immunology Practices

Automating the allergy & immunology CoverMyMeds integration frees up prior authorization coordinators to focus on complex cases and patient advocacy. By accelerating approval times for critical medications like biologics and IVIG, Klivira helps improve time-to-treatment, enhances patient satisfaction, and optimizes revenue cycle performance for the practice.

Frequently asked questions

How does Klivira's integration with CoverMyMeds specifically benefit allergy and immunology practices?

Klivira automates the ePA process for high-cost A&I medications like biologics and IVIG, which are frequently processed via CoverMyMeds. This reduces manual data entry, accelerates submission, and improves tracking, directly addressing the administrative burden specific to these complex therapies.

What types of allergy & immunology medications require ePA through CoverMyMeds?

Common medications include biologics for asthma (e.g., Xolair, Dupixent, Nucala), atopic dermatitis (Dupixent), and chronic urticaria (Xolair). Additionally, immunoglobulin therapies (IVIG/SCIG) and certain advanced allergen immunotherapy formulations often require electronic prior authorization.

Does Klivira integrate with our existing EMR to facilitate CoverMyMeds submissions for A&I?

Yes, Klivira integrates with major EMR systems using standards like SMART on FHIR. This allows for automated extraction of clinical data—such as diagnoses, lab results, and treatment plans—directly from the patient chart to populate and submit PAs through CoverMyMeds.

How does Klivira handle payer-specific requirements for allergy & immunology PAs not fully covered by CoverMyMeds?

Klivira's platform intelligently routes PAs and supplements CoverMyMeds submissions with additional payer-specific documentation or portal interactions when necessary. This ensures comprehensive coverage for all A&I prior authorization needs, even for payers with unique requirements.

What data is typically exchanged between our EMR, Klivira, and CoverMyMeds for A&I PAs?

Key data exchanged includes patient demographics, ICD-10 diagnosis codes, CPT codes for procedures, NDCs or HCPCS codes for medications, relevant lab results (e.g., IgE levels, FEV1 for asthma), and clinical notes supporting medical necessity, all securely transmitted in compliance with HIPAA.

Related coverage

Other allergy-immunology prior auth workflows

Ready to automate this workflow for this specialty?

See how Klivira automates prior authorizations for your team.

Request a demo